Management of Chemotherapy Induced Thrombocytopenia
Publication Date: October 10, 2023
Last Updated: November 14, 2023
Use of Platelet Transfusion for Severe CIT
We recommend empiric platelet transfusion for platelet count <10 x109 /L
6731
Thrombocytopenia Receptor Agonists for CIT in Solid Tumors
This subcommittee acknowledges the lack of high-quality data (phase 3 trials) demonstrating efficacy for TPO-RA in the management of CIT. As such, any guidance below regarding the use of TPO-RA in management of CIT should be considered suggestions (or weak recommendations).
Title
Management of Chemotherapy Induced Thrombocytopenia
Authoring Organization
International Society on Thrombosis and Haemostasis
To continue viewing this pocket guide, please purchase it.